Literature DB >> 7509211

Stem cell factor and basic fibroblast growth factor are synergistic in augmenting committed myeloid progenitor cell growth.

J L Gabrilove1, K White, Z Rahman, E L Wilson.   

Abstract

Stem cell factor (SCF) and basic fibroblast growth factor (bFGF) are hematopoietic cytokines produced by bone marrow stromal cells. It is known that, although SCF and bFGF have limited clonogenic activity on their own, they can augment colony-stimulating factor (CSF)-mediated progenitor cell growth. Because these factors are both sequestered by stromal cells, we examined their interaction on progenitor cell growth in conjunction with granulocyte-macrophage-CSF (GM-CSF). In this study, we show that clonogenic growth derived from low-density bone marrow cells stimulated by GM-CSF is significantly augmented (P < .001) in the presence of maximal (100 ng/mL) concentrations of SCF in combination with 100 ng/mL of bFGF. When CD34+ cells are used, the synergistic effect of bFGF and SCF for GM-CSF-mediated progenitor cell growth is further increased, resulting in as much as a sevenfold increase in detectable colony-forming units granulocyte-macrophage (P < .001). These data suggest that the synergistic activity of bFGF and SCF is mediated directly on hematopoietic precursors. These observations suggest that bFGF and SCF, concentrated locally on stromal cell surfaces, might interact in concert with other hematopoietic cytokines to regulate stem cell proliferation and differentiation in hematopoietic niches in the bone marrow.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509211

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  ZNF198-FGFR1 transforms Ba/F3 cells to growth factor independence and results in high level tyrosine phosphorylation of STATS 1 and 5.

Authors:  D Smedley; A Demiroglu; M Abdul-Rauf; C Heath; C Cooper; J Shipley; N C Cross
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

2.  Signaling from fibroblast growth factor receptor 2 in immature hematopoietic cells facilitates donor hematopoiesis after intra-bone marrow-bone marrow transplantation.

Authors:  Akio Shigematsu; Ming Shi; Mitsuhiko Okigaki; Yasushi Adachi; Naoko Koike; Jishan Che; Masayoshi Iwasaki; Hiroaki Matsubara; Masahiro Imamura; Susumu Ikehara
Journal:  Stem Cells Dev       Date:  2010-09-10       Impact factor: 3.272

Review 3.  Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia. French INSERM Research Network on Myelofibrosis with Myeloid Metaplasia.

Authors:  M C Le Bousse-Kerdilès; M C Martyré
Journal:  Springer Semin Immunopathol       Date:  1999

Review 4.  [The 8p11 myeloproliferative syndrome].

Authors:  A Reither; R Hehlmann; J M Goldman; N C Cross
Journal:  Med Klin (Munich)       Date:  1999-04-15

5.  Ex vivo expansion of primitive hematopoietic cells for cellular therapies: An overview.

Authors:  T A McAdams; C E Sandstrom; W M Miller; J G Bender; E T Papoutsakis
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

6.  Stem cell factor stimulates neurogenesis in vitro and in vivo.

Authors:  Kunlin Jin; Xiao Ou Mao; Yunjuan Sun; Lin Xie; David A Greenberg
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

Review 7.  Roles of FGF signaling in stem cell self-renewal, senescence and aging.

Authors:  Daniel L Coutu; Jacques Galipeau
Journal:  Aging (Albany NY)       Date:  2011-10       Impact factor: 5.682

8.  TGF-{beta} maintains dormancy of prostatic stem cells in the proximal region of ducts.

Authors:  Sarah N Salm; Patricia E Burger; Sandra Coetzee; Ken Goto; David Moscatelli; E Lynette Wilson
Journal:  J Cell Biol       Date:  2005-06-27       Impact factor: 10.539

9.  Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties.

Authors:  Vera Levina; Adele M Marrangoni; Richard DeMarco; Elieser Gorelik; Anna E Lokshin
Journal:  PLoS One       Date:  2008-08-27       Impact factor: 3.240

10.  bFGF blockade reduces intraplaque angiogenesis and macrophage infiltration in atherosclerotic vein graft lesions in ApoE3*Leiden mice.

Authors:  Laura Parma; Hendrika A B Peters; Thijs J Sluiter; Karin H Simons; Paolo Lazzari; Margreet R de Vries; Paul H A Quax
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.